Litigation

Recent Posts

Hung Jury Results In Mistrial In New Jersey Accutane Case Alleging Bowel Injury
Posted on 23 Dec 2011 by Tom Moylan

ATLANTIC CITY, N.J. - A New Jersey state court Accutane trial ended Dec. 22 with a hung jury, a source told Mealey Publications ( Chetan P. Tanna, et al. v. Hoffman-La Roche Inc. , No. ATL-L-3366-04, N.J. Super., Atlantic Co.). The source said that... Read More

Tags: IBD , inflammatory bowel disease , Chetan P. Tanna v. Hoffman-La Roche , Accutane , isotretinoin , Litigation , lawsuit , Roche

Supreme Court Rules Against University In Patent Case
Posted on 7 Jun 2011 by Melissa Ritti

WASHINGTON, D.C. - (Mealey's) In a dispute over patented HIV-detection kits, a divided U.S. Supreme Court on June 6 affirmed a Federal Circuit U.S. Court of Appeals ruling that the Bayh-Dole Act does not automatically vest title to federally funded... Read More

Tags: Supreme Court , Federal Circuit , Stanford , Bayh-Dole Act , United States v. Dubilier Condenser Corp. , Intellectual Property , HIV-detection kits , Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems , Litigation , Cetus , Patents , Roche , inventions

Watchdog Group Makes 2nd Push To Ban Diet Pill
Posted on 15 Apr 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney stones and pancreatic... Read More

Tags: Pondimin , Wyeth , obesity , Food and Drug Administration , Darvon , Public Citizen , Alli , diet drugs , diet pill , Meridia , FDA , Orlistat , fen-phen , fenfluramine , Redux , Litigation , GlaxoSmithKline , Roche , Xenical

Abbott Withdraws Diet Pill Meridia In United States, Canada
Posted on 8 Oct 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. — (AP) Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure from health regulators who say the drug increases the risk of heart attack and stroke in patients... Read More

Tags: weight loss , Wyeth , Vivus Inc. , Dr. John Jenkins , Food and Drug Administration , Abbott Laboratories , diet drugs , diet pill , Meridia , FDA , fen-phen , Arena Pharmaceuticals , Litigation , lawsuit , Roche , Health Canada , Xenical , Qnexa